Article
Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin.
Cancer research - 15 Apr 2001
Cadoret A, Ovejero C, Saadi-Kheddouci S, Souil E, Fabre M, Romagnolo B, Kahn A, Perret C
Abstract excerpt
Inappropriate activation of the Wnt/beta-catenin signaling, resulting mainly from activating mutations of the beta-catenin gene, has been implicated recently in the development of hepatocellular carcinoma (HCC). We have generated transgenic mice expressing an oncogenic form of beta-catenin in their hepatocytes to analyze the effect of deregulated beta-catenin signaling on liver homeostasis. These mice rapidly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
